THE SHINGRIX VACCINE DEC. 4TH, 2017

Dec 04, 2017

By Michelle Saunders

Post
Share on

A new vaccine called Shingrix, approved by Health Canada last in October, and available in January, has been shown in clinical trials to be more than 90 per cent effective at preventing the debilitating nerve pain of shingles in people over age 50.  The Shingrix vaccine is not made with live attenuated zoster virus, as the previous shingles vaccine was – but was created from a protein taken from an inactivated form of the virus, which triggers an immune response in the body, boosted by what’s called an adjuvant. To learn more about it we speak with Dr. Iris Gorfinkel, a family physician/researcher and Andre Picard, a health reporter and columnist at The Globe and Mail.

Zoomer Kids
You Don't Have To Be A Zoomer To Love Zoomer Radio.
Check out what the Kids have to say!
Join Our Fan Club
Coverage Area
Downtown Toronto
96.7FM
Toronto HD
96.3 HD-2
Kingston to Windsor, Parry Sound to Pittsburgh
AM740
ZoomerRadio Logo

Recently Played: